Cormorant Asset Management, LP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 0 | 17,878,594 | +17,878,594 | 0 | 207,034,119 | 14.29% | +207,034,119 |
| ABIVAX SA(ABVX) | 2,130,000 | 1,950,000 | -180,000 | 16,294,500 | 165,555,000 | 11.42% | +149,260,500 |
| RAPPORT THERAPEUTICS INC(RAPP) | 2,940,921 | 3,192,521 | +251,600 | 33,438,272 | 94,817,874 | 6.54% | +61,379,602 |
| EYEPOINT PHARMACEUTICALS INC(EYPT) | 8,325,000 | 8,325,000 | 0 | 78,338,250 | 118,548,000 | 8.18% | +40,209,750 |
| BRIGHT MINDS BIOSCIENCES INC | 1,059,331 | 1,059,331 | 0 | 27,659,132 | 64,259,018 | 4.43% | +36,599,886 |
| NEWAMSTERDAM PHARMA COMPANY | 2,175,000 | 2,175,000 | 0 | 39,389,250 | 61,857,000 | 4.27% | +22,467,750 |
| CENTESSA PHARMACEUTICALS PLC | 2,086,600 | 1,925,000 | -161,600 | 27,417,924 | 46,681,250 | 3.22% | +19,263,326 |
| KORRO BIO INC | 465,000 | 465,000 | 0 | 5,807,850 | 22,268,850 | 1.54% | +16,461,000 |
| CORBUS PHARMACEUTICALS HLDGS | 2,375,000 | 2,375,000 | 0 | 16,387,500 | 30,043,750 | 2.07% | +13,656,250 |
| MBX BIOSCIENCES INC(MBX) | 700,000 | 1,225,000 | +525,000 | 7,987,000 | 21,437,500 | 1.48% | +13,450,500 |
| ARCELLX INC | 800,000 | 775,000 | -25,000 | 52,680,000 | 63,627,500 | 4.39% | +10,947,500 |
| ORUKA THERAPEUTICS INC(ORKA) | 0 | 533,340 | +533,340 | 0 | 10,256,128 | 0.71% | +10,256,128 |
| METSERA INC | 400,000 | 400,000 | 0 | 11,380,000 | 20,932,000 | 1.44% | +9,552,000 |
| EDGEWISE THERAPEUTICS INC(EWTX) | 4,251,992 | 4,010,000 | -241,992 | 55,743,615 | 65,042,200 | 4.49% | +9,298,585 |
| CG ONCOLOGY INC(CGON) | 625,000 | 625,000 | 0 | 16,250,000 | 25,175,000 | 1.74% | +8,925,000 |
| PHARVARIS N V | 1,454,660 | 1,363,200 | -91,460 | 25,602,016 | 34,011,840 | 2.35% | +8,409,824 |
| INSMED INC(INSM) | 540,000 | 430,000 | -110,000 | 54,345,600 | 61,924,300 | 4.27% | +7,578,700 |
| ENGENE HOLDINGS INC | 2,323,595 | 2,323,595 | 0 | 8,457,886 | 15,870,154 | 1.10% | +7,412,268 |
| AVIDITY BIOSCIENCES INC | 200,000 | 300,000 | +100,000 | 5,680,000 | 13,071,000 | 0.90% | +7,391,000 |
| AMYLYX PHARMACEUTICALS INC(AMLX) | 0 | 500,000 | +500,000 | 0 | 6,795,000 | 0.47% | +6,795,000 |
| TARSUS PHARMACEUTICALS INC(TARS) | 300,000 | 300,000 | 0 | 12,153,000 | 17,829,000 | 1.23% | +5,676,000 |
| CRINETICS PHARMACEUTICALS IN(CRNX) | 400,000 | 400,000 | 0 | 11,504,000 | 16,660,000 | 1.15% | +5,156,000 |
| CABALETTA BIO INC | 5,000,000 | 5,000,000 | 0 | 7,600,000 | 11,700,000 | 0.81% | +4,100,000 |
| BIOAGE LABS INC(BIOA) | 2,140,605 | 2,140,605 | 0 | 8,840,699 | 12,586,757 | 0.87% | +3,746,058 |
| BRIDGEBIO PHARMA INC(BBIO) | 1,600,000 | 1,400,000 | -200,000 | 69,088,000 | 72,716,000 | 5.02% | +3,628,000 |
| GH RESEARCH PLC(GHRS) | 2,009,482 | 1,916,439 | -93,043 | 24,495,586 | 27,405,078 | 1.89% | +2,909,492 |
| ALUMIS INC | 2,147,396 | 2,147,396 | 0 | 6,442,188 | 8,568,110 | 0.59% | +2,125,922 |
| AXSOME THERAPEUTICS INC(AXSM) | 100,000 | 100,000 | 0 | 10,439,000 | 12,145,000 | 0.84% | +1,706,000 |
| BIOMEA FUSION INC | 3,570,872 | 3,570,872 | 0 | 6,427,570 | 7,213,161 | 0.50% | +785,591 |
| VAXCYTE INC(PCVX) | 175,000 | 175,000 | 0 | 5,689,250 | 6,303,500 | 0.43% | +614,250 |
| ARCUTIS BIOTHERAPEUTICS INC(ARQT) | 1,000,000 | 775,000 | -225,000 | 14,020,000 | 14,608,750 | 1.01% | +588,750 |
| ENLIVEN THERAPEUTICS INC | 200,000 | 200,000 | 0 | 4,012,000 | 4,094,000 | 0.28% | +82,000 |
| BIOHAVEN LTD(BHVN) | 10,000 | 10,000 | 0 | 141,100 | 150,100 | 0.01% | +9,000 |
| VYNE THERAPEUTICS INC | 1,370,938 | 0 | -1,370,938 | 2,262,048 | 0 | — | -2,262,048 |
| KALA BIO INC | 603,027 | 0 | -603,027 | 2,870,409 | 0 | — | -2,870,409 |
| STOKE THERAPEUTICS INC(STOK) | 254,161 | 0 | -254,161 | 2,884,727 | 0 | — | -2,884,727 |
| AARDVARK THERAPEUTICS INC | 800,189 | 0 | -800,189 | 10,818,555 | 0 | — | -10,818,555 |
| JANUX THERAPEUTICS INC(JANX) | 1,500,000 | 850,000 | -650,000 | 34,650,000 | 20,774,000 | 1.43% | -13,876,000 |
| CARGO THERAPEUTICS INC | 3,381,277 | 0 | -3,381,277 | 13,930,861 | 0 | — | -13,930,861 |
| PRAXIS PRECISION MEDICINES I(PRAX) | 1,625,000 | 1,000,000 | -625,000 | 68,331,250 | 53,000,000 | 3.66% | -15,331,250 |
| ARS PHARMACEUTICALS INC | 1,100,000 | 0 | -1,100,000 | 19,195,000 | 0 | — | -19,195,000 |
| HELIX ACQUISITION CORP II | 2,909,000 | 0 | -2,909,000 | 30,893,580 | 0 | — | -30,893,580 |
| VERONA PHARMA PLC | 350,000 | 0 | -350,000 | 33,103,000 | 0 | — | -33,103,000 |
| MERUS N V | 1,120,000 | 0 | -1,120,000 | 58,912,000 | 0 | — | -58,912,000 |
| MOONLAKE IMMUNOTHERAPEUTICS(MLTX) | 8,494,151 | 1,994,173 | -6,499,978 | 400,923,927 | 14,298,220 | 0.99% | -386,625,707 |